Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
136 results
- D3.27 - Chlorhexidine as a Hidden Everyday Allergen
D3.290 - Manifestations of allergic skin lesions in the early childhood and adult population: Epidemiological manifestations of diseases
D3.316 - Impact of chronic urticaria on the quality of life of patients followed up at a university hospital Nis-Serbia
D3.344 - Biological therapy for severe chronic spontaneous urticaria associated with autoimmune atrophic gastritis
D3.35 - Severe atopic dermatitis poorly controlled, or something else?
D3.36 - Contact allergy to sodium metabisulfite in Singapore: A single-center retrospective study of patch test data from 2004 to 2021
D3.37 - Beware of the Rare: AGEP
D3.39 - Autoimmune Progesterone Dermatitis Case Report
D3.42 - Symmetrical drug-related intertriginous and flexural exanthema related to symptomatic slow-acting drug for osteoarthritis (SYSADOA) – a case report
D3.44 - The Role of Medical History and Diagnostic Testing in Identifying Post-Surgical Allergic Reactions
D3.84 - Delayed hypersensitivity to hydroxychloroquine with positive patch test
D3.89 - Unexpected Culprit: The Role of Acrylates in Recurrent Anaphylaxis and Antibiotic Hypersensitivity
D3.94 - Optimizing the Diagnosis and Treatment of Psoriasis Associated with Streptococcal Infection
D3.137 - Effectiveness of Dupilumab in improving Quality of Life in patients with "steroid-resistant" asthma and severe atopic dermatitis
D3.17 - Systemic Histaminergic Findings in Children with Chronic Urticaria
D3.18 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
D3.19 - Evaluation of allergens in Atopic Dermatitis in children between 6 months and 18years
D3.20 - Searching for an Alternative Contrast Agent in a Patient Allergic to Multiple Nonionic Iodinated Contrast Media
D3.22 - Fixed Drug Eruption in a Patient with Vitiligo: localized patch testing as a diagnostic tool
D3.28 - Comparative Efficacy and Safety of Omalizumab Intended copy Biosimilar vs. Biologic in Chronic Spontaneous Urticaria
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Current page
4
Page
5
Page
6
Page
7
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download